Surgical sealants and adhesives are materials used to repair injured tissues and prevent air and fluid leakages during or after surgeries. These are used for minimising blood losses, replacing staples and sutures for better closure, and strengthening wound areas without limiting tissue movement. The surgical sealants and adhesives market covered in this report is segmented by product into biological sealants, synthetic sealants, and semi-synthetic sealants. The biological sealants are made up of biological material that is used to repair injured tissues and prevent air and fluid leakages during or after the surgeries. These are used for various indications such as tissue sealing, tissue engineering, and hemostasis and are used by end-uses such as hospitals, clinics, and others. The surgical sealants and adhesives market research report is one of a series of new reports from The Business Research Company that provides surgical sealants and adhesives market statistics, including surgical sealants and adhesives industry global market size, regional shares, competitors with a surgical sealants and adhesives market share, detailed surgical sealants and adhesives market segments, market trends and opportunities, and any further data you may need to thrive in the surgical sealants and adhesives industry. This surgical sealants and adhesives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global surgical sealants and adhesives market grew from $2.39 billion in 2022 to $2.63 billion in 2023 at a compound annual growth rate (CAGR) of 9.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The surgical sealants and adhesives market is expected to grow from $3.38 billion in 2027 at a CAGR of 6.5%. The rising number of surgical procedures is predicted to contribute to the growth of the surgical sealants and adhesives market. In recent years, the continuous surge in surgical procedures is registered attributing to the growing prevalence of obesity and other lifestyle diseases, increasing incidence of spinal and sports-related injuries, and rising geriatric population. The old-age population is more prone to chronic, heart, and other diseases, thereby undergoing surgical procedures. According to the World Health Organization, the number of people over the age of 65 is projected to increase from 1 billion in 2020 to 2.1 billion by 2050, globally. The advances in surgical procedures are anticipated to hinder the growth of the surgical sealants and adhesives market. Minimal invasive surgeries are replacing conventional surgical procedures, eliminating complications including bleeding and air leakage and therefore, limiting the use of any surgical sealants and adhesives. According to the American Society of Plastic Surgeons (ASPS), approximately 18 million people undergoing surgical and minimally invasive cosmetic procedures in the USA. Hence, the growing number of minimally invasive surgeries and other substitutes for conventional surgical processes is predicted to impact the growth of the market over the forthcoming years. Several companies operating in the market are focusing on product portfolio expansion into untapped geographies. For instance, in January 2020, Terumo Corporation announced the launch of AQUABRID, a new surgical sealant in the EMEA market. AQUABRID is specially developed for aortic procedures to stop bleeding during and post surgeries. The company earlier introduced this product in Japan under the brand name Hydrofit and is under the process of registration in Eastern Europe, the Middle East, and Africa. In December 2021, Becton, Dickinson and Company, a US-based medical technology company, acquired Tissuemed, Ltd for an undisclosed amount. The acquisition would complete BD’s core portfolio and enable BD to further strengthen the surgical sealants portfolio. Tissuemed is a England-based surgical sealants manufacturer. Major players in the surgical sealants and adhesives market are Baxter International Inc., B. Braun Melsungen AG, Cohera Medical, Inc., CryoLife Inc., C.R. Bard Inc., CSL Limited (CSL Behring), Johnson & Johnson (Ethicon, Inc.), Sanofi, Ocular Therapeutix, Inc., and Sealantis Ltd. North America was the largest region in the surgical sealants and adhesives market in 2022. Western Europe was the second largest region in the global surgical sealants and adhesives market report. The regions covered in the global surgical sealants and adhesives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the surgical sealants and adhesives report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The patient handling equipment market consists of sales of fibrin sealants, collagen based adhesives, gelatin based adhesives, cyanoacrylates, polymeric hydrogels, and urethane based adhesives. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global surgical sealants and adhesives market is segmented - 1) By Product: Biological Sealants, Synthetic Sealants, Semi-Synthetic Sealants 2) By Indication: Tissue Sealing, Tissue Engineering, Hemostasis 3) By End Use: Hospitals, Clinics, Other End Uses

Surgical equipments are tools or devices that perform such functions as cutting, dissecting, grasping, holding, retracting, or suturing. Most surgical instruments are made from stainless steel. The main types of surgical equipment are surgical sutures and staples, handheld surgical devices and equipment, electrosurgical devices, and equipment. The surgical sutures, also known as stitches, are sterile surgical threads used to repair cuts. They are used to close incisions in surgery. Staples is a town used as a centre for the sale or exportation of commodities in bulk. The type of expenditure is public or private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The surgical equipment market research report is one of a series of new reports from The Business Research Company that provides surgical equipment market statistics, including surgical equipment industry global market size, regional shares, competitors with a surgical equipment market share, detailed surgical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the surgical equipment industry. This surgical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global surgical equipment market grew from $27.05 billion in 2022 to $29.04 billion in 2023 at a compound annual growth rate (CAGR) of 7.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The surgical equipment market is expected to grow to $36.49 billion in 2027 at a CAGR of 5.9%. The growing demand for minimally invasive surgery (MIS) will increase the demand for advanced surgical equipment. An MIS refers to any surgical procedure that requires minimal incisions as opposed to traditional or open surgery used for the same purpose. Preference for MIS procedures increased due to their multiple advantages such as short healing and recovery time, minimal scarring, cost-effectiveness, minimal trauma and pain, and decreased risk of infections and complications. Medical technology innovations led to the development of advanced surgical equipment such as Da Vinci surgical systems, C-arm devices, and electrosurgical and power-assisted surgical equipment. These devices which enable MIS will drive the surgical equipment market during the forecast period. Interest rates globally are forecasted to rise in most of the developing and developed economies during the forecast period; this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates are expected to rise to 3.5% by 2021. These factors are expected to have a negative impact on the market as borrowing money becomes expensive, making it harder for companies in the surgical equipment market to raise funds for developing new devices thereby affecting the market growth. Surgical equipment manufacturers are offering next-generation ultrasonic surgical devices to simplify complex surgical procedures. Modern ultrasonic surgical devices are multifunctional instruments capable of performing tissue plane dissection, coagulation, and transection during laparoscopic or open surgical procedures. Next-generation ultrasonic devices feature adaptive tissue technology. In this technology ultrasonic algorithm actively monitors the condition of the tissue within the jaws of the device and allows the system to intelligently sense and respond to changes in patient tissue conditions. The system modulates energy delivery based on tissue thickness and tissue type to optimize vessel sealing and provide for secure and reliable large vessel sealing. Ethicon’s Harmonic devices feature adaptive tissue technology Major companies in the surgical equipment market include Johnson & Johnson (J&J), Stryker Corporation, Intuitive Surgical, B. Braun Melsungen AG, and Getinge Group. North America was the largest region in the global surgical equipment market in 2022. Western Europe was the second-largest region in the global surgical equipment market. The regions covered in the surgical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the surgical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The surgical equipment market consists of sales of instruments such as forceps & spatulas, retractors, dilators, graspers, auxiliary instruments, and cutter instruments that are used for surgeries. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global surgical equipment market is segmented - 1) By Type: Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

Surgical arms are a vital component used in the field of surgery, especially for performing minimally invasive procedures. These are robotic arms that are controlled by surgions. The surgical imaging arms market covered in this report is segmented by product type into G-arm surgical imaging devices, C-arm surgical imaging devices, O-arm surgical imaging devices; by technology into image intensifier C-arms, flat panel detector C-arms; by application into orthopaedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, other applications; by end-user into hospitals and ambulatory surgical centers, academic research institutes. The surgical imaging arm market research report is one of a series of new reports from The Business Research Company that provides surgical imaging arm market statistics, including surgical imaging arm industry global market size, regional shares, competitors with a surgical imaging arm market share, detailed surgical imaging arm market segments, market trends and opportunities, and any further data you may need to thrive in the surgical imaging arm industry. This surgical imaging arm market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global surgical imaging arms market size grew from $1.23 billion in 2022 to $1.32 billion in 2023 at a compound annual growth rate (CAGR) of 7.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The surgical imaging arms market size is expected to grow to $1.75 billion in 2027 at a CAGR of 7.3%. High demand for mini C-arms devices is expected to boost market growth during the forecast period. Globally, companies are engaged in the development and manufacturing of novel equipment that assists surgeons in carrying out surgical procedures smoothly and efficiently. The rising demand for mini C-arms devices can be attributed to features, such as their miniaturized size, easy adaptability in the operation theatre, and lower price than other types of C-arms. For instance,in July 2022, Fujifilm, a Germany-based company that produces and distributes photographic and imaging products and services, launched FDR CROSS. FDR CROSS is a versatile, hybrid C-arm and portable x-ray machine. The technology offers a more effective and streamlined workflow by capturing fluoroscopic and radiographic pictures on a single platform. Thus, the rising demand for mini C-arms combined with their easy-to-use features is expected to drive market growth. The high cost of surgical imaging arms is anticipated to hamper market growth during the forecast period. Recently, the prices of surgical arms are increasing owing to constant research and development to introduce new features in the devices. The price of C-arm imaging devices ranges from $25,000 to greater than $70,000. The advanced C-arms such as Siemens Cios Fusion of Siemens Healthcare and OEC 9900 of GE Healthcare range between $1,50,000 and $2,00,000. The average refurbished mini C-arm price ranges between $19,000 and $50,000. Health care settings face challenges with the high costs of these devices that are predicted to hinder market growth. Integration of technology for real-time visualization during surgeries is gaining significant popularity in the surgical imaging arms market. With the increasing number of patients requiring surgeries, the scope and complexity of surgical interventions such as image-guided minimally invasive surgery continue to surge. In January 2020, Philips announced major innovations in its Zenition mobile C-arm platform. With the new user interface, the clinician will be able to operate C-arm inside the sterile field, reducing the communication burden with the operator and making it more intuitive to control the system. Moreover, the platform is extended to integrate intravascular ultrasound (IVUS) for peripheral vascular procedures for improving workflow and streamlining the operating room. In August 2021, TBS Medical Equipment Services, a US-based company that provides medical facilities and services, acquired Omni Imaging Service (Omni) for an undisclosed amount. Through this acquisition, TBS Medical Equipment Services bolstered its foundation and boosted its capacity to deliver high-quality services across the nation. Omni Imaging Service (Omni) is a US-based OEC C-Arm parts and services company. Major players in the surgical imaging arms market are GE Healthcare, Hologic Inc., ATON GmbH, Whale Imaging Inc., Siemens Healthcare, Shimadzu Corp., Canon Medical Systems Corporation, Medtronic plc, Ziehm Imaging, and Philips Healthcare. North America was the largest region in the surgical imaging arms market in 2022. Asia-Pacific was the second largest region in the surgical imaging arms market. The regions covered in the surgical imaging arms market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the surgical imaging arms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The surgical imaging arms market consists of sales of bronchoscopes, heolders & positioners, and retractor systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global surgical imaging arms market is segmented - 1) By Product Type: G-Arm Surgical Imaging Devices, C-Arm Surgical Imaging Devices, O-Arm Surgical Imaging Devices 2) By Technology: Image Intensifier C-Arms, Flat Panel Detector C-Arms 3) By Application: Orthopaedic And Trauma Surgeries, Neurosurgeries, Cardiovascular Surgeries, Gastrointestinal Surgeries, Other Applications 4) By End-User: Hospitals And Ambulatory Surgical Centers, Academic Research Institutes

Surgical sutures and staples are medical devices used by surgeons to hold skin, internal organs, blood vessels, or any other tissues together after they have been severed during surgery. Sutures and staples hold incised body parts together until they are completely healed. These devices can either be absorbable or non-absorbable. An absorbable suture breaks down in tissue and degrades as a wound or incision heals. A non-absorbable suture resists the body's attempt to dissolve it. Non-absorbable sutures must be removed after a surface incision heals. The main types of surgical sutures and staples are surgical sutures and surgical staples. Surgical staples are specialized staples utilized in surgery in place of sutures to close skin wounds or connect or remove parts. The surgical staples include disposable surgical staplers and reusable surgical staplers. The surgical sutures are absorbable and non-absorbable. The various end-users are hospitals, ambulatory surgical centres (ASCS), and clinics. The surgical sutures and staples market research report is one of a series of new reports from The Business Research Company that provides surgical sutures and staples market statistics, including surgical sutures and staples industry global market size, regional shares, competitors with a surgical sutures and staples market share, detailed surgical sutures and staples market segments, market trends and opportunities, and any further data you may need to thrive in the surgical sutures and staples industry. This surgical sutures and staples market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global surgical sutures and staples market size will grow from $12.28 billion in 2022 to $13.06 billion in 2023 at a compound annual growth rate (CAGR) of 6.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The surgical sutures and staples market size is expected to grow to $16.86 billion in 2027 at a CAGR of 6.6%. The increase in the number of surgical procedures across the globe is an important driver for the surgical sutures and staples market. This is mainly because surgeries are an important treatment procedure used to repair an injury, relieve symptoms, restore function, remove diseased organs, or replace anatomical parts of the body. Moreover, surgeries are also performed under emergency conditions such as trauma, fracture, and acute infection. For instance, according to the US Department of Health & Human Services, there were 22 million surgeries performed in the US out of which 52.7% were in outpatient surgeries. It is estimated that 234 million surgeries are performed throughout the world every year. Increasing adoption of minimally invasive surgeries is a major restraint for the surgical sutures and staples market. Minimally invasive surgery is a surgical technique to operate with less damage to the body than the open surgery technique. It also involves less pain, shorter hospital stays, and fewer complications than open surgery. This has led to the increasing adoption of these surgeries. For instance, according to a Canada-based market research firm iData Research, more than 693,000 robotic-assisted procedures were performed in the USA, out of which around 86% were minimally invasive surgeries. The use of disposable surgical sutures and staple devices is an emerging trend in the surgical sutures and staples market. This is mainly due to heightened concerns regarding communicable infections associated with the use of reusable sutures and staple devices for surgeries. Disposable surgical sutures and staple devices are designed in such a way that they are discarded after one use and cannot be reused. In this regard, the Centers for Disease Control and Prevention (CDC) provides protocols to prevent the spread of pathogens and promotes the use of disposable devices. The FDA has classified surgical staples as class I medical devices and implantable surgical staples as class II medical devices. Class, I medical devices are those which do not require pre-marketing submissions to the FDA whereas the Class II category requires pre-marketing submissions. Moreover, the FDA has also stated some measures and protocols for the sterilization of these devices that should be strictly followed to avoid the risk of infections. Hence, the regulatory scenario related to surgical staplers will keep a check on the companies that manufacture these devices. In 2021, BD seals acquired the surgical sealant maker Tissuemed. This acquisition is providing the opportunity to equip surgeons with a more robust, highly integrated portfolio of surgical solutions. Tissuemed is a UK- based self-adhesive film company that is helping surgeons to close and seal sutured and stapled internal tissues. Major players in the surgical sutures and staples market are Ethicon Endo-Surgery Inc., Stryker Corporation, Smith & Nephew PLC., Conmed Corporation, Medtronic PLC., Johnson & Johnson, B.Braun Melsungen AG, Baxter International Inc., Alcon Laboratories Inc., and Dextera Surgical Inc. North America was the largest region in the global surgical sutures and staples market in 2022. Western Europe was the second-largest region in the surgical sutures and staples market. The regions covered in the global surgical sutures and staples market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the surgical sutures and staples market include Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The surgical sutures and staples market consists of sales of surgical sutures (absorbable, non-absorbable), and surgical staples (disposable surgical staplers, reusable surgical staplers). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products. The global surgical sutures and staples market is segmented - 1) By Type: Surgical Sutures, Surgical Staples 2) By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Clinics 3) By Surgical Sutures: Absorbable, Non Absorbable 4) By Surgical Staples: Disposable Surgical Staplers, Reusable Surgical Staplers

Hand-held surgical instruments are usually built of premium stainless steel and come in a wide range of sizes, styles, and shapes appropriate for various surgical procedures. Hand-held surgical instruments are used in the surgical procedures and operated on while being held in hand. A wide variety of hand-held surgical instruments are used in numerous surgical operations, including scalpels, forceps, scissors, and retractors. The main product types of hand-held surgical instruments are forceps, retractors, dilators, graspers, scalpels, and others. Forceps are used for securely grabbing, pulling, or holding items, especially during delicate operations. A forceps is a two-bladed tool with a handle that can be used for various tasks, including managing sterile dressings, squeezing or gripping tissues, and others. Neurosurgery, cardiovascular, orthopedic, plastic and reconstructive surgery, obstetrics and gynecology are the applications of hand-held surgical instruments. These instruments are used by hospitals, clinics, and ambulatory surgical centers. The hand-held surgical instruments market research report is one of a series of new reports from The Business Research Company that provides hand-held surgical instruments market statistics, including hand-held surgical instruments industry global market size, regional shares, competitors with a hand-held surgical instruments market share, detailed hand-held surgical instruments market segments, market trends and opportunities, and any further data you may need to thrive in the hand-held surgical instruments industry. This hand-held surgical instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global hand-held surgical instruments market size grew from $5.99 billion in 2022 to $6.48 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hand-held surgical instruments market size is expected to grow to $8.63 billion in 2027 at a CAGR of 7.4%. An increase in the geriatric population is driving the hand-held surgical instruments market. The geriatric population consists of adults 65 years of age and older. People at this age are more prone to fall ill and catch a severe disease that needs proper treatment and surgical intervention. Surgical instruments are used in surgeries and carrying out treatment for various diseases. For instance, according to a report by United Nations on World Population Ageing 2020, a US-based intergovernmental organization, the world population aging in 2020 was about 727 million people aged over 65 years and expected to reach 1.5 billion in 2050. Throughout the world, there is an increased population of over-aged 65-year-olds, which stood at 9.3% in 2020 and is expected to reach 16.0% by 2050. Therefore, the increasing geriatric population will propel the hand-held surgical instruments market. Technological advancement is a key trend gaining popularity in the hand-held surgical instruments market. Major players in the hand-held surgical instruments market are adopting smart surgical instruments to treat various diseases. Smart surgical instruments are user-friendly, advanced tools that save time and money. For instance, in November 2021, OrthAlign, a US-based medical equipment manufacturer, introduced a new, hand-held smart surgical instrument called Lantern for full and partial knee replacements. The solution offers streamlined workflows to reduce operating room wait times and support numerous operating rooms at once without requiring the investment in hardware or pre-operative imaging required by various computer-assisted surgical systems. In October 2020, Katena Products Inc., a surgical equipment provider that includes cannulas, forceps, needle holders, phaco choppers, scissors, spatulas, and many more, acquired Micro Select for an undisclosed amount. With this acquisition, Katena will expand its production of fine ophthalmic tools and manufacturing facilities. Micro Select Instruments Inc. is full-service surgical instrument manufacturing and repair company. Major players in the hand-held surgical instruments market are Johnson & Johnson, B Braun Melsungen AG, Medtronic, Zimmer Biomet Holdings, KLS MARTIN GROUP, Integra LifeSciences Corporation, Smith & Nephew, Aspen Surgical, CooperSurgical Inc., Thompson Surgical Instruments Inc., Becton Dickinson and Company, Swann-Morton Ltd., Peters Surgical, Huaiyin Medical Instruments CoLtd and CONMED Corporation. North America was the largest region in the hand-held surgical instruments market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hand-held surgical instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the hand-held surgical instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The hand-held surgical instruments market consists of sales of cannulas, dermatome, and trocars. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hand held surgical instruments market is segmented - 1) By Product: Forceps, Retractors, Dilators, Graspers, Scalpels, Other Products 2) By Application: Neurosurgery, Cardiovascular, Orthopedic, Plastic And Reconstructive Surgery, Obstetrics And Gynecology, Other Applications 3) By End User: Clinics, Ambulatory Surgical Centers, Other End Users

Cardiovascular surgery devices and equipment are used in cardiac surgery and other cardiovascular procedures performed to repair structural defects of the cardiovascular system and damaged or blocked valves and vessels. The main product types in the cardiovascular surgery devices and equipment are beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposables. Cardiopulmonary bypass equipment is used in open-heart surgeries and is operated by perfectionists. The various applications are congenital heart defects, cardiac arrhythmia, coronary heart disease, congestive heart failure, and other applications. These are used in home and ambulatory care, hospitals, diagnostic laboratories, and research laboratories. The cardiovascular surgery devices and equipment market research report is one of a series of new reports from The Business Research Company that provides cardiovascular surgery devices and equipment market statistics, including cardiovascular surgery devices and equipment industry global market size, regional shares, competitors with a cardiovascular surgery devices and equipment market share, detailed cardiovascular surgery devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular surgery devices and equipment industry. This cardiovascular surgery devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global cardiovascular surgery devices and equipment market size will grow from $1.68 billion in 2022 to $1.75 billion in 2023 at a compound annual growth rate (CAGR) of 3.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cardiovascular surgery devices and equipment market size is expected to grow to $1.91 billion in 2027 at a CAGR of 2.2%. The rising geriatric population along with the rising deaths related to cardiovascular disorders is driving the cardiovascular surgical devices market. According to American Heart Association (AHA), in the US, approximately 43.7 million aged above 60 suffered from cardiovascular disorders. It is also reported by AHA that death related to cardiac diseases amount to 17.3 million per year and is expected to rise to more than 23.6 million by 2030, worldwide. Due to these factors, a higher number of surgeries are being performed, thereby driving the market. The cardiovascular surgical devices market may be restrained due to stringent and longer approval processes by the regulatory authorities. According to a researcher from Harvard Business School, innovative first-mover products such as implantable defibrillators or transcatheter heart valves are delayed for approvals by FDA, thereby adding to the development cost to the manufacturer. For new cardiovascular devices (first-entrants), the innovator spends 7.2 months longer than the first follow-on innovator. For example, Edwards Lifesciences trans-catheter heart valve was approved in Europe 4 years before it was approved in the USA. The study also estimated the financial loss associated with the delay in getting the approval. The delay may cost firms an average of $6.7 million to the already existing $94 million average prices to introduce a new medical device to market, thereby hampering companies’ pursuit of innovations. Companies in the cardiovascular surgery devices and equipment market are investing in second-generation bioresorbable stents and as well rectifying the glitches which occurred in the earlier version of bioresorbable stents. This advancing segment is poised to garner $247 million by 2025. Due to the all-new device features such as thinner strut thicknesses, faster resorption times, and better radial force, these are expected to grow at a higher growth rate. A higher elective procedure volume due to the less-invasive nature of PCIs, when compared to coronary artery bypass grafting, is expected to drive bioresorbable stents adoption. For instance, Amaranth Medical has developed three medical devices with thinner strut thickness, the latest bearing a magnitude of 100 microns. The U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) made public, its priority list for medical device guidance documents. This would allow the companies in promoting innovation and as well save them from the stringent consequences of non-approval of any product. Thus, a clearer and transparent approval method would drive the cardiovascular surgical devices market in the future. Major players in the cardiovascular surgery devices and equipment market are Abbott Laboratories, Boston Scientific Corporation, Cook Medical, C.R.Bard, Abiomed, St.Jude medical, Angiodynamics Inc., Transmedics, Terumo cardiovascular systems corporation, and Edwards Life Science Corporation. North America was the largest region in the global cardiovascular surgery devices and equipment market in 2022. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cardiovascular surgery devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The cardiovascular surgery devices and equipment market consist of sales of perfusion disposables, beating heart surgery systems, cardiopulmonary bypass equipment, and cardiac ablation devices that are used for cardiovascular surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global cardiovascular surgery devices and equipment market is segmented - 1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables 2) By End User: Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research laboratories 3) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications

Minimally invasive surgery devices are surgical tools that require fewer incisions of a smaller size or have a quicker healing process. A minimally invasive medical device is implanted inside the patient during surgery. The main product types of minimally invasive surgery devices are handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, monitoring and visualization devices. The electrosurgical devices are used to destroy tissue, incise tissue, and control bleeding by coagulating blood. The various applications of minimal invasive surgery devices are laparoscopy, cardiovascular, cosmetic surgery, orthopedic surgery, obstetrics and gynecology, ophthalmology, neurosurgery, urology, and others that are used by end-users such as hospitals, ambulatory surgical centres (ASCS), and research institutes. The minimally invasive surgery devices market research report is one of a series of new reports from The Business Research Company that provides minimally invasive surgery devices market statistics, including minimally invasive surgery devices industry global market size, regional shares, competitors with a minimally invasive surgery devices market share, detailed minimally invasive surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive surgery devices industry. This minimally invasive surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global minimal invasive surgery devices market grew from $28.98 billion in 2022 to $31.64 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The minimal invasive surgery devices market is expected to grow from $39.48 billion in 2027 at a CAGR of 5.7%. The increasing awareness for minimally invasive surgeries among people is driving the minimally invasive surgery devices market. The minimally invasive surgeries require less/tiny cuts in the skin as compared to traditional surgical methods and aid in lesser pain, short hospital stay, less scarring, minimized chances of bleeding and infections, and low tissue damage. According to the German Heart Surgery Report, the heart operations using ECC (extracorporeal circulation) declined due to achievement of established innovations in minimally invasive therapeutic options in heart surgeries. Furthermore, 51.1% of heart valve operations performed out of the total cardiac surgical procedures in Germany were through the single-valve procedure, out of which 38.5% of them were through minimal invasive heart surgeries. Thus, the growing demand for minimally invasive surgery (MIS) will increase the demand for the minimally invasive surgical devices market. The rising trade barriers are expected to have a negative impact on the minimally invasive surgery devices market growth. Many countries placed trade restrictions, especially on imports, to boost local production. For instance, Brexit is likely to lead to more trade restrictions between the UK and other countries in Europe. The US is also implementing several trade restrictions, especially with China, to boost its local production. For instance, the US government imposed an additional 25% tariff on approximately $16 billion worth of imports from China, including minimally invasive surgical devices and equipment and supplies. These trade restrictions are likely to limit the growth of demand going forward by leading to raised prices. Technologically advanced minimally invasive surgery (MIS) devices with improvements in image guidance, fiber-optics, mini dental implants, and robotic control systems are increasingly opted by patients to treat medical conditions such as aneurysms, cardiac procedures, dental and spinal procedures. Less-invasive surgical procedures with enhanced capabilities in the areas of imaging, micromachining, robotic equipment and components, software systems, and others are becoming popular in the healthcare industry. For instance, video-assisted thoracoscopic surgery (VATS), is a minimally invasive surgical procedure performed to completely remove an organ of the human body to treat traumatic injury, infection, or cancer in the lungs. VATS is performed using a video camera where a small tube called a thoracoscope to which the camera is connected, is inserted through a small incision between the ribs. Furthermore, imaging technology involved in MIS, virtual reality (VR) is becoming a significant area of development. Other MIS techniques are applied to perform surgeries such as single-site laparoscopic surgery, robotic surgeries, needlescopic surgery, cardiac and spinal surgeries, and others. Food and Drug Administration Act (FDA) regulates the minimally invasive surgical devices market in the United States of America. The firms manufacturing robotic minimally invasive surgical devices have to list down any possible risks to health and measures taken by them so that the device addresses health hazards if any stated by FDA. However, the FDA is concerned about the health care providers and patients for not being aware of the safety and effectiveness of these devices as they should not be used in mastectomy procedures or prevention or treatment of cancer. Major players in the minimally invasive surgery devices market are Abbott Laboratories, GE Healthcare, Medtronic PLC., Siemens Healthineers, Smith & Nephew PLC., Medtronic PLC., Stryker Corporation, Boston Scientific Corporation, Ethicon Inc., and B. Braun Melsungen AG. North America was the largest region in the minimally invasive surgery devices market in 2022. Western Europe was the second largest region in the global minimally invasive surgery devices market report. The regions covered in the global minimally invasive surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the minimally invasive surgery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The minimally invasive surgery devices market consists of sales of graspers, retractors/elevators, dilators, suturing instruments, laparoscopes, gastroscope, cystoscope, and ureteroscop. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global minimal invasive surgery devices market is segmented - 1) By Product Type: Handheld Instruments, Inflation Devices, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring & Visualization Devices 2) By Application: Laparoscopy, Cardiovascular, Cosmetic Surgery, Orthopedic Surgery, Obstetrics And Gynecology, Ophthalmology, Neurosurgery, Urology, Other Applications 3) By End Users: Hospitals, Ambulatory Surgical Centers (ASCS), Research Institutes

Robotic surgery devices help doctors perform complex minimally invasive operations with precision and flexibility. The main product and services in the robotic surgery devices market are robotic systems, instruments and accessories, and services. The services are provided by the robots and are also called robot-assisted surgery services. The various surgery types are urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. These are used in hospitals and ambulatory surgery centres. The robotic surgery devices market research report is one of a series of new reports from The Business Research Company that provides robotic surgery devices market statistics, including robotic surgery devices industry global market size, regional shares, competitors with a robotic surgery devices market share, detailed robotic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery devices industry. This robotic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global robotic surgery devices market size will grow from $6 billion in 2022 to $6.84 billion in 2023 at a compound annual growth rate (CAGR) of 14.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global robotic surgery devices market size is expected to grow from $11.65 billion in 2027 at a CAGR of 14.2%. The rise in demand for minimally invasive technology is driving the robotic surgery devices market. Minimally Invasive (MI) surgery devices are equipped with imaging and catheter technologies that can be easily inserted into any part of the body. Robotic surgery procedures are usually associated with minimally invasive surgeries. These technologies are mainly used for heart, laparoscopy, orthopedic, gynecological, and urological surgeries. Robotic surgeries were introduced to reduce patient hospital length of stay (LOS), pain, complications, return to work time, and reoperations. According to the Intuitive Surgical company report, there is a 24% growth year on year for instruments and accessories. For robotic systems, the company has gained 16% growth and the overall robotic surgery devices market is growing at a rate of 13% -16%. The Intuitive Surgical company estimates that more than 1.2 million surgical procedures were done by using their robotic systems. Consumer preferences are changing, and hospitals are adopting robotic surgery devices to create more value and cost-effective surgical procedures. Expensive robotic surgery is hampering the robotic surgery devices market. Robotic surgery is comparatively more expensive than other traditional ways of surgeries as it is associated with a lot of complications, requires highly trained senior doctors to operate robotic systems/instruments, complex technical operations, and maintenance. A single robotic system costs around $2 million and the surgery costs about a range of $3000 - $6000. The annual maintenance cost of robotic surgery devices usually costs between $100,000 - $170,000. The largest robotic surgery device manufacturer Intuitive Surgical supplies the single-use or disposable surgical tools used for robotic arms for surgeries. This is one of the reasons that robotic surgeries are more costly. The huge cost associated with robotic surgeries is therefore hindering the market growth. The advances in surgical products and technologies in the health care industry are creating more opportunities in the robotic surgery devices market. Increasing investments in R&D is helping investors to create value for the customers by producing medical-surgical products like robotic surgery devices by using the latest technologies. With the use of robotic systems that are equipped with optical imaging, surgical tools, instruments, and accessories, the surgeries are made easier. Some of the surgical advances that are creating more value and opportunity in the healthcare industry include 3-D high definition endoscope (Multi-Angle Rear-Viewing Endoscopic tool) devices for Brain surgery, Smart surgical glasses (equipped with a video camera and Head-mounted monitor) that act like computers, and can use for live observation of surgeries, surgical robots with artificial intelligence that acts as doctors, and humanoid robots which are used for highly critical surgeries in eye and brain. The other advanced surgical tool is remote robotics, which is used to assist with surgery from any remote location. Therefore, robotic surgery devices are playing an important role in the healthcare industry with their technological advancements and innovations. In February 2020, Medtronic PLC., a US-based medical device manufacturer, acquired Digital Surgery for an undisclosed amount. The acquisition would help Medtronic in clinical decision support and reduce its cost. It will also help them to grow in the robotic surgery vertical. Digital Surgery is a UK-based manufacturer of digital surgical tools. Major players in the robotic surgery devices market are Intuitive Surgical, Stryker, Medtronic, Smith & Nephew, TransEnterix, Mazor Robotics, Medrobotics, Accuray, THINK Surgical, and TINAVI Medical Technology Co. Ltd. North America was the largest region in the robotic surgery devices market in 2022. Western Europe was the second largest market in global robotic surgery devices market. The regions covered in the global robotic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the robotic surgery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. Robotic surgery equipment market consist of sales of robotic systems, instruments and accessories that are used for robotic surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global robotic surgery devices market is segmented - 1) By Product and Service: Robotic systems, Instruments & Accessories, Services 2) By Surgery Type: Urological surgery, Gynecological surgery, Orthopedic surgery, Neurosurgery, Other Surgery Types 3) By End User: Hospitals, Ambulatory Surgery Centers